CVS Group (LON:CVSG) Insider Purchases £2,553,920 in Stock

CVS Group plc (LON:CVSG) insider Richard Gray purchased 2,000 shares of the stock in a transaction dated Monday, January 5th. The stock was purchased at an average cost of £1,276.96 per share, for a total transaction of £2,553,920.

CVS Group Stock Performance

LON:CVSG opened at GBX 1,305.73 on Friday. The stock has a market cap of £923.24 million, a P/E ratio of 17.74, a PEG ratio of 1.77 and a beta of 1.02. The company has a quick ratio of 0.90, a current ratio of 1.09 and a debt-to-equity ratio of 110.52. The business’s 50-day moving average price is GBX 1,226.36 and its two-hundred day moving average price is GBX 1,248.34. CVS Group plc has a twelve month low of GBX 804 and a twelve month high of GBX 1,648.

CVS Group (LON:CVSG) last posted its quarterly earnings data on Tuesday, October 7th. The company reported GBX 80.10 earnings per share for the quarter. CVS Group had a net margin of 3.20% and a return on equity of 7.86%. As a group, equities analysts predict that CVS Group plc will post 93.9393939 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research firms have recently weighed in on CVSG. Berenberg Bank reissued a “buy” rating and issued a GBX 2,000 target price on shares of CVS Group in a research note on Tuesday, November 18th. Royal Bank Of Canada increased their price target on shares of CVS Group from GBX 1,500 to GBX 1,900 and gave the stock an “outperform” rating in a research note on Tuesday, October 21st. Peel Hunt reaffirmed a “buy” rating and issued a GBX 1,600 price target on shares of CVS Group in a research note on Tuesday, November 18th. Jefferies Financial Group increased their price objective on CVS Group from GBX 1,250 to GBX 1,420 and gave the stock a “hold” rating in a report on Wednesday, October 22nd. Finally, Deutsche Bank Aktiengesellschaft raised their price objective on CVS Group from GBX 1,500 to GBX 1,700 and gave the company a “buy” rating in a research report on Tuesday, October 21st. Four analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of GBX 1,724.

About CVS Group

CVS Group is an AIM-listed provider of veterinary services with operations in the UK and Australia. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group now operates c.470 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.